Local Institution - 0239

Hangzhou, Zhejiang 310003

0 studies enrolling now · 1 studies all time

What they study most

Lung Cancer

Studies at this site

• An Investigational Immuno-therapy Study of Nivolumab, or Nivolumab in Combination With Ipilimumab, or Placebo in Patients With Extensive-Stage Disease Small Cell Lung Cancer (ED-SCLC) After Completion of Platinum-based Chemotherapy — Completed